Cleveland Clinic is launching a new initiative utilizing quantum technologies and artificial intelligence for clinical applications.
Cleveland Clinic is partnering with the Novo Nordisk Foundation, a Denmark company focused on medical treatment and research, to launch the Cleveland Clinic – Denmark: Quantum-AI Biomedical Frontiers Fellowship Program.
Under the program, the Novo Nordisk Foundation will award up to $6.2 million over the next three years to facilitate the exchange of 12 researchers, according to an Aug. 5 news release from Cleveland Clinic.
Each researcher will receive a three-year term to conduct advanced research at either Cleveland Clinic or in Denmark. In Cleveland, the fellows will also have the chance to collaborate with IBM researchers through Cleveland Clinic's Discovery Accelerator partnership.
The program will work to harness quantum technologies and AI to focus on scientific areas such as enhanced diagnostic precision, innovative drug discovery, optimization of clinical trials, and personalized medicine development.